Servier

Welcome to our page. Servier is committed to therapeutic progress to serve patient needs.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Throug

h precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.

----

To report a suspected adverse event with a Servier drug 👉 https://bit.ly/435zpoI

24/06/2026

✨ Let’s move for a healthier tomorrow. Join the Fun Run. Raise awareness for people living with digestive cancers.

This July, join the Fun Run & Walk 👣 in Munich and stand together with patients, advocates, and healthcare professionals to raise awareness for digestive cancers 💙

Already signed up? Amazing—see you there! 🙌
Missed it so far? There’s still time to be part of it ⏳

At Servier, we are proud to support this initiative, that brings a community together around one shared purpose.
👉 Register now: https://funrun.digestivecancers.eu/

Show up. Or sign up. Either way—be part of the movement.

Digestive Cancers Europe - for Patients ; Outdoor Against Cancer

23/06/2026

Today we celebrate the International Women in Engineering Day 👩‍🔬💡

At Servier, we are proud to recognize the incredible contributions of women engineers who help transform scientific innovation into medicines reaching patients worldwide 🌍💊

Across our Industry teams — from manufacturing and quality to supply chain, digital and industrial excellence — their expertise drives safety, performance, quality and innovation every single day.

🎥 To mark this year’s INWED, discover “One Job, Many Stories” — a campaign showcasing the diversity of journeys, experiences and aspirations of our women engineers.
👏 Listen to inspiring voices from across the Group: Andrea, Cliona, Guylaine, Sandra, Shiping, Tiphaine, Violette, and Weronika.

Read more about the campaign 👉 https://servier.com/en/newsroom/one-job-many-stories-women-engineers-industry/

18/06/2026

Two worlds, one purpose, everyday routines leading to something essential.

While your day unfolds through simple, familiar moments, ours is dedicated to precision, care, and every detail that makes a difference behind the scenes.

Because everyday routines — yours and ours — lead to something essential!

At Servier, every step matters. Moved by you.

🎥 Discover the story behind the science.

17/06/2026

💬 “Patients speak, we listen… and we act together.” This is how we define patient engagement at Servier.

In this interview, Nicolas Garnier, Chief Patient Officer at Servier, shares how we are strengthening our commitment to patient engagement worldwide.

🤝 Built on trust, co-creation, and partnership, our approach involves collaboration with nearly 200 patient associations across all stages of our medicines’ lifecycle.

Our commitments are clear:
📌 By 2030, 100% of our clinical trial protocols will be developed with patients
📌 All our therapeutic areas will be supported by patient advisory councils
📌 All beyond-the-pill solutions will be co-developed with patients

🌍 From glioma to cardiometabolic diseases and oncology, our patient advisory councils ensure diversity, inclusion, and meaningful collaboration across five continents.

Learn more about our commitments for patients https://servier.com/en/patients/

15/06/2026

What if one simple step could mean something bigger? 👣

This July, join the Fun Run & Walk in Munich—where patients, advocates, and professionals come together for one shared purpose: raising awareness for digestive cancers 💙

Whether it’s a 3K walk or 5K run, every step counts. Your presence matters.

Why join?
✨ Support awareness & early detection
🤝 Connect with a life-minded community
🌿 Do something positive for your own well-being

No pressure. Just purpose.
📍 Munich 🗓️ July 3, 2026 ⏰ 6:30 AM
👉 Register now: https://funrun.digestivecancers.eu/

At Servier, we’re proud to support this initiative, helping drive collective action for greater awareness and early detection.

✨ Let’s move for a healthier tomorrow. Join the Fun Run. Raise awareness for people living with digestive cancers.

Digestive Cancers Europe - for Patients ; Outdoor Against Cancer

12/06/2026

🧑‍🔬 Behind every scientific breakthrough, there are people driven by curiosity and purpose.

🧬 At Servier, Tímea Szabó works in the innovative field of targeted protein degradation, which explores how specific proteins can be broken down to better understand complex biological mechanisms.

🤝 Her work contributes to advancing research approaches by combining cutting-edge science, collaboration, and continuous learning within our global R&D ecosystem.

From conducting postdoctoral research to leading projects and mentoring young scientists, Tímea's career path reflects the dynamic and collaborative environment fostered by the ShineDocs community.

📖 Explore more stories in the SUNDARI Journal: https://bit.ly/49mKO9K

10/06/2026

Let’s move together for a stronger cause & connect with a passionate community and support better outcomes for people affected by digestive cancers.! 👣

This year, we proudly support the Fun Run & Walk initiated by Digestive Cancers Europe - for Patients and Outdoor Against Cancer . With Digestive Cancers Europe - for Patients, we have co‑developed the Fun Run slogan 👉 “Let’s move for a healthier tomorrow. Join the Fun Run. Raise awareness for people living with digestive cancers.”

This July, join us—uniting patients, advocates, and healthcare professionals to raise awareness of digestive cancers 💙

Whether you choose a 3K walk or a 5K run, every step makes a difference. No pressure. Just purpose.

📍 Munich 🗓️ July 3, 2026 ⏰ 6:30 AM
👉 Register now: https://funrun.digestivecancers.eu/

Show up. Move together. Let’s make every step count.

09/06/2026

🧠 Did you know the symptoms of diffuse glioma?

Glioma can impact essential functions like memory, speech, and movement. Persistent headaches, seizures, or changes in vision or memory should not be ignored.

80% of patients report seizures as their first symptom.

⚠️ Glioma is the most common primary brain tumor in adults. While brain tumors remain complex to treat, early detection and appropriate management are important factors in patient care.

🌈 Let’s come together to color up for hope.

Learn more about glioma 🔗 https://servier.com/en/newsroom/folders/glioma-aggressive-brain-tumor/

08/06/2026

🗣️ “I believe that this interplay between body and mind is absolutely crucial when dealing with this kind of cancer. That’s why I wanted to use my Instagram profile to encourage other patients to enjoy life and live each day to the fullest.”

To mark the , we had the pleasure of speaking with Lena. 🧠

Lena was only 48 when she was diagnosed with blastoma Grad 4, a fast-growing brain tumor. At first, she lost strength in her body and never imagined this condition could affect so much of her life.

Through her journey, Lena chose transparency, resilience and sharing. As a patient, and now a voice for awareness, she reminds us how powerful understanding, support and community can be.

🎥 Watch her inspiring story.

You can also find Lena - .kortholt on Instagram.

07/06/2026

Tomorrow is !
🧠 Diffuse glioma: who is at risk?
Understanding risk factors and recognizing symptoms are essential to help support earlier diagnosis and appropriate care.

To date, no precise cause of glioma has been identified. However, certain factors may be associated with a higher risk:
📌 Median age at diagnosis: 36–45 years
📌 Annual incidence: 0.8 per 100,000 people
📌 Median survival: 17.8 years

Oligodendrogliomas and astrocytomas generally grow more slowly and are less aggressive than glioblastomas.

🌈 Let’s come together to color up for hope.

Learn more about glioma 🔗 https://servier.com/en/newsroom/folders/glioma-aggressive-brain-tumor/

Adresse

50, Rue Carnot
Suresnes
92150

Téléphone

+33 1 55 72 60 00

Site Web

https://servier.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Servier publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.